A potentially new treatment for tuberculosis; will a diarylquinoline work for leprosy?
Franzblau
Scott
S
Institute of Tuberculosis Research, University of Illinois Abraham Lincoln School of Medicine, Chicago, Ill., USA.
D035843:Biomedical Research / Q000592:standards; D064687:Diarylquinolines; D004359:Drug Therapy, Combination; D024841:Fluoroquinolones / Q000494:pharmacology; D006801:Humans; D009166:Mycobacterium leprae / Q000187:drug effects* / Q000235:genetics; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics; D011804:Quinolines / Q000494:pharmacology*; D012294:Rifamycins / Q000494:pharmacology; D014376:Tuberculosis / Q000188:drug therapy* / Q000382:microbiology
D064687:Diarylquinolines; D024841:Fluoroquinolones; D011804:Quinolines; D012294:Rifamycins; C493870:bedaquiline